Bio Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Emcure Pharmaceuticals and its subsidiary Gennova have resolved all legal disputes with US-based HDT Bio Corp. The parties have entered into a long-term agreement to develop mRNA vaccines against various infectious diseases in India and other countries. As part of their agreement, HDT has granted a license to Gennova to use HDT's patented mRNA vaccine technology in multiple fields

Under the settlement, the litigation between them, including before US courts and the arbitral tribunal in London, has been settled and dismissed, Emcure said in a statement.

Emcure Pharmaceuticals and Gennova Biopharmaceuticals resolve legal disputes with HDT Bio Corp, collaborating on mRNA vaccines.

Emcure and Gennova to resume mRNA collaboration with HDT

Results show statistically significant decreases in stroke volume, edema, and necrotic area versus controls